HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical application of thyrotropin-releasing hormone to neurogenic bladder caused by olivo-ponto-cerebellar atrophy].

Abstract
The effect of thyrotropin-releasing hormone (TRH) on vesicourethral dysfunction in two patients with olivo-ponto-cerebellar atrophy was studied by urodynamic examination. The two patients had difficulty of urination with 200 ml of residual urine. Cystometrogram and electromyogram showed autonomous contraction without detrusor-sphincter dyssynergia. After administration of TRH, the symptom and volume of residual urine was not improved, autonomous contraction was not changed, while prostatic urethral pressure in urethral pressure profile was significantly increased in both patients.
AuthorsK Murayama, T Katsumi
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 31 Issue 3 Pg. 495-8 (Mar 1985) ISSN: 0018-1994 [Print] Japan
PMID3927664 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Thyrotropin-Releasing Hormone
Topics
  • Adult
  • Atrophy (complications)
  • Brain Diseases (complications)
  • Cerebellum (pathology)
  • Drug Evaluation
  • Humans
  • Male
  • Middle Aged
  • Olivary Nucleus (pathology)
  • Pons (pathology)
  • Thyrotropin-Releasing Hormone (therapeutic use)
  • Urinary Bladder, Neurogenic (drug therapy, etiology, physiopathology)
  • Urodynamics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: